TY - JOUR
T1 - EANM/ESC guidelines for radionuclide imaging of cardiac function
AU - Hesse, B.
AU - Lindhardt, T. B.
AU - Acampa, W.
AU - Anagnostopoulos, C.
AU - Ballinger, J.
AU - Bax, J. J.
AU - Edenbrandt, L.
AU - Flotats, A.
AU - Germano, G.
AU - Stopar, T. Gmeiner
AU - Franken, P.
AU - Kelion, A.
AU - Kjaer, A.
AU - Le Guludec, D.
AU - Ljungberg, M.
AU - Maenhout, A. F.
AU - Marcassa, C.
AU - Marving, J.
AU - McKiddie, F.
AU - Schaefer, W. M.
AU - Stegger, L.
AU - Underwood, R.
PY - 2008/4
Y1 - 2008/4
N2 - Radionuclide imaging of cardiac function represents a number of well-validated techniques for accurate determination of right (RV) and left ventricular (LV) ejection fraction (EF) and LV volumes. These first European guidelines give recommendations for how and when to use first-pass and equilibrium radionuclide ventriculography, gated myocardial perfusion scintigraphy, gated PET, and studies with non-imaging devices for the evaluation of cardiac function. The items covered are presented in 11 sections: clinical indications, radiopharmaceuticals and dosimetry, study acquisition, RV EF, LV EF, LV volumes, LV regional function, LV diastolic function, reports and image display and reference values from the literature of RVEF, LVEF and LV volumes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "prevailing or general consensus". The guidelines are designed to assist in the practice of referral to, performance, interpretation and reporting of nuclear cardiology studies for the evaluation of cardiac performance.
AB - Radionuclide imaging of cardiac function represents a number of well-validated techniques for accurate determination of right (RV) and left ventricular (LV) ejection fraction (EF) and LV volumes. These first European guidelines give recommendations for how and when to use first-pass and equilibrium radionuclide ventriculography, gated myocardial perfusion scintigraphy, gated PET, and studies with non-imaging devices for the evaluation of cardiac function. The items covered are presented in 11 sections: clinical indications, radiopharmaceuticals and dosimetry, study acquisition, RV EF, LV EF, LV volumes, LV regional function, LV diastolic function, reports and image display and reference values from the literature of RVEF, LVEF and LV volumes. If specific recommendations given cannot be based on evidence from original, scientific studies, referral is given to "prevailing or general consensus". The guidelines are designed to assist in the practice of referral to, performance, interpretation and reporting of nuclear cardiology studies for the evaluation of cardiac performance.
KW - Cardiac function
KW - EANM/ESC guidelines
KW - Nuclear imaging
UR - http://www.scopus.com/inward/record.url?scp=40949100800&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40949100800&partnerID=8YFLogxK
U2 - 10.1007/s00259-007-0694-9
DO - 10.1007/s00259-007-0694-9
M3 - Article
C2 - 18224320
AN - SCOPUS:40949100800
VL - 35
SP - 851
EP - 885
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
SN - 0340-6199
IS - 4
ER -